MED Stock Recent News
MED LATEST HEADLINES
Medifast's Q1 2023 EPS of $3.67 beats by $1.27 and revenue of $349M beats analysts' expectations by $29.5M. For Q2 2023, the company expects a ~25% decline in revenue and a ~50% decline in EPS.
Medifast's (MED) first-quarter 2023 results reflect lower sales on reduced Coach productivity and cost inflation. While earnings increase year over year.
Medifast, Inc. (NYSE:MED ) Q1 2023 Earnings Conference Call May 1, 2023 4:30 PM ET Company Participants Steve Zenker - Vice President of Investor Relations Dan Chard - Chairman & Chief Executive Officer Jim Maloney - Chief Financial Officer Conference Call Participants Linda Bolton-Weiser - D.A. Davidson Operator Good afternoon, and welcome to the Medifast First Quarter 2023 Earnings Conference Call.
Medifast's (MED) first-quarter performance is likely to reflect the adverse impacts of macroeconomic volatility and increased inflation.
Medifast stock was truly exceptional, as it embodied the desirable traits of value, growth, and dividend stocks all in one. However, latest quarterly earnings were down around 10% YoY.
The latest dividend yields over 6% on its market price. The latest dividend payout is less than 50% of its latest quarter earnings.
Medifast operates in the health and wellness industry and is the owner of the OPTAVIA brand, a popular weight loss and diet program. The company generates its sales through a large network of independent coaches who work at arms-length with its customer base.
Medifast's (MED) fourth-quarter 2022 results reflect reduced Coach productivity and cost inflation. While earnings increase year over year, revenues dip
Medifast, Inc. (NYSE:MED ) Q4 2022 Earnings Conference Call February 21, 2023 4:30 PM ET Company Participants Reed Anderson - Investor Relations, ICR, Inc. Dan Chard - Chief Executive Officer Jim Maloney - Chief Financial Officer Conference Call Participants Linda Bolton Weiser - D. A. Davidson & Co. Operator Good afternoon, and welcome to the Medifast Fourth Quarter and Fiscal Year 2022 Earnings Conference Call.
Medifast (MED) delivered earnings and revenue surprises of 69.72% and 9.96%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?